SCHEMBL5808258

SCHEMBL5808258

OCCn1cc(-c2ccnc(N[C@@H]3CCCC[C@H]3O)n2)c2cccnc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 6/20 0.61
CCNB2 O95067 5/20 0.61
CCNB1 P14635 5/20 0.61
CCNB3 Q8WWL7 5/20 0.61
GSK3B P49841 4/20 0.48
RET P07949 4/20 0.46
FLT3 P36888 3/20 0.46
MKNK2 Q9HBH9 3/20 0.46
CDC7 O00311 2/20 0.46
PLK4 O00444 2/20 0.46
JAK2 O60674 2/20 0.46
MAP4K4 O95819 2/20 0.46
PIM1 P11309 2/20 0.46
PRKACA P17612 2/20 0.46
KDR P35968 2/20 0.46
JAK3 P52333 2/20 0.46
PIM3 Q86V86 2/20 0.46
HIPK2 Q9H2X6 2/20 0.46
IRAK4 Q9NWZ3 2/20 0.46
AKT3 Q9Y243 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5807755 0.90 CDK1 (0.60) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3770147 0.87 CDK1 (0.78) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3775610 0.85 CCNB2 (0.65) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3775606 0.85 CCNB2 (0.65) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL5808261 0.77 CCNB2 (0.53) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL13061452 0.76 CDK1 (0.78) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3763115 0.76 CDK1 (1.00) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3769906 0.75 CCNB2 (0.65) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL3769904 0.75 CCNB2 (0.65) CDK1CCNB2CCNB1CCNB3GSK3B
SCHEMBL13008036 0.74 CDK1 (0.74) CDK1CCNB2CCNB1CCNB3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050076-A1 PYRIMIDINYL SUBSTITUTED FUSED-PYRROLYL COMPOUNDS USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 WO disclosed